IsoRay - About the company
IsoRay is a public company based in Richland (United States), founded in 1998. It operates as an Isotopes for malignant cancer treatment through Brachytherapy. IsoRay has raised an undisclosed amount in funding. The company has 16 active competitors, including 7 funded and 4 that have exited. Its top competitors include companies like Koya Medical, Sensus Healthcare and Xoft.
Company Details
Isoray develops, manufactures, and markets isotopes for use in the medical treatment of various malignant diseases through Brachytherapy. In March of 2003, IsoRay Medical received clearance to market Cesium-131 from the Food and Drug Administration for the treatment of prostate, breast, liver, brain, lung, head and neck cancers and other malignant diseases. Isoray's GliaSite RTS balloon catheter offers physicians GliaSite Radiation Therapy System is available for brachytherapy of the resection bed following the surgical removal of gliomas and brain metastases. On July 28, 2005, IsoRay Medical, Inc. (Medical) became a wholly-owned subsidiary of Century Park Pictures Corporation. Pursuant to a merger. Century changed its name to IsoRay, Inc. (IsoRay or the Company).
- Website
- isoray.com
- Social
Key Metrics
Founded Year
1998
Location
Richland, United States
Stage
Public
Latest Funding Round
Investors
Ranked
8th among 16 active competitors
Employee Count
62 as on Dec 31, 2022
Similar Companies
Exit Details
Public
Legal entities associated with IsoRay
IsoRay is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Isoray, Inc. CIN: 411458152 , United States, Active | Jul 11, 2019 | - | 62 (As on Dec 31, 2022) | - |
IsoRay's IPO details
IsoRay got listed on Nov 04, 2005.
Click here to take a look at IsoRay's IPO in detail
Sign up to download IsoRay's company profile
IsoRay's funding and investors
IsoRay has raised funding over 1 round. IsoRay has 1 institutional investor.
Here is the list of recent funding rounds of IsoRay:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 11, 2018 | 5819955 | Post IPO | 8358185 | 9817207 | 6268907 | 2158216 |
Access funding benchmarks and valuations. Sign up today!View details of IsoRay's funding rounds and investors
IsoRay's founders and board of directors
Founder? Claim ProfileIsoRay's employee count trend
IsoRay has 62 employees as of Dec 22. The total employee count is 7.0% more than what it was in Dec 21. Here is IsoRay's employee count trend over the years:
Uncover IsoRay's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
IsoRay's Competitors and alternates
Top competitors of IsoRay include Koya Medical, Sensus Healthcare and Xoft. Here is the list of Top 10 competitors of IsoRay, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Koya Medical 2018, Oakland (United States), Series B | Provider of smart wearable compression technology for lymphedema and venous diseases | $37M | 65/100 | |
2nd | Sensus Healthcare 2010, Boca Raton (United States), Public | Medical device company specializing in non-invasive skin cancer and keloid treatments | $12.2M | - | 60/100 |
3rd | Xoft 1998, Sunnyvale (United States), Acquired | Electronic brachytherapy for multiple cancers | $117M | 50/100 | |
4th | Theragenics 1981, Buford (United States), Acquired | Manufacturer of surgical products and brachytherapy devices | $9.44M | 40/100 | |
5th | C4 Imaging 2009, Bellaire (United States), Seed | Provider of Image-guided procedures for the treatment of prostate cancer | $7.35M | 38/100 | |
6th | Concure Oncology 2014, Mercer Island (United States), Series A | Breast microseed based radiotherapy for women diagnosed with early-stage breast cancer | $14M | 37/100 | |
7th | CivaTech Oncology 2006, Durham (United States), Series A | Provider of polymer-based devices for localized low dose radiation therapy or brachytherapy | $12.4M | 34/100 | |
8th | IsoRay 1998, Richland (United States), Public | Isotopes for malignant cancer treatment through Brachytherapy | - | 32/100 | |
9th | RadioGel 2006, Richland (United States), Series A | Developing innovative radionuclide therapy for solid tumors, currently in clinical trials | $725K | - | 31/100 |
10th |  Mission-Driven Tech™ 2022, New York City (United States), Seed | Provider of awareness products combating cervical cancer | $20K | 29/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on IsoRay's competitors? Click here to see the top ones
IsoRay's Investments and acquisitions
IsoRay has made no investments or acquisitions yet.
Reports related to IsoRay
Here is the latest report on IsoRay's sector:
News related to IsoRay
Filter this list•
•
•
•
•
•
Isoray Completes Merger with Viewpoint MolecularFinSMEs•Feb 07, 2023•IsoRay, Viewpoint Molecular Targeting
•
STOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Isoray, Inc. – ISRICrowdNewswire•Nov 15, 2022•IsoRay
•
•
Halper Sadeh LLC Investigates TALO, ISR, FCRD, SESNPR Newswire•Oct 28, 2022•Halper Sadeh, Talos Energy, EnVen Energy, IsoRay and 5 others
•
The M&A Class Action Firm Announces the Investigation of Isoray, Inc.PR Newswire•Oct 28, 2022•Monteverde, IsoRay
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about IsoRay
Explore our recently published companies
- Cold Solutions Kenya - Kiambu based, 2020 founded, Series B company
- Apollo Diamond - Boston based, 1990 founded, Funding Raised company
- CLARKDALE WATER ASSOCIATION - United States based, Funding Raised company
- Ira H. Hayes Memorial Applied Learning Center - United States based, Funding Raised company
- Qtrack.com - 2021 founded, Funding Raised company
- Valinor - Washington, DC based, 2024 founded, Series A company
